Provided by Tiger Trade Technology Pte. Ltd.

Aerovate Therapeutics, Inc.

9.80
0.0000
Volume:- -
Turnover:2.77M
Market Cap:284.05M
PE:-5.76
High:9.80
Open:9.80
Low:9.80
Close:9.80
52wk High:884.98
52wk Low:9.80
Shares:28.99M
Float Shares:11.96M
Volume Ratio:- -
T/O Rate:- -
Dividend:2.40
Dividend Rate:24.49%
EPS(TTM):-1.7025
EPS(LYR):-2.4361
ROE:-59.01%
ROA:-36.18%
PB:3.79
PE(LYR):-4.02

Loading ...

Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Major Issues Report

Form 8-K - Current report
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 01, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities